← FDA Drug Approvals (Drugs@FDA)

ANTHIM

BLA · Biologics License Application · Sponsor: ELUSYS THERAPEUTICS INC · Approved 2016-03-18

Drug application

FDA Application #

BLA125509

Application type

Biologics License Application

Brand name

ANTHIM

Generic name

OBILTOXAXIMAB

Active ingredients

OBILTOXAXIMAB

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

ELUSYS THERAPEUTICS INC

Manufacturer

Elusys Therapeutics, Inc.

First approval

2016-03-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown